|
Market Data
Baxter International Inc.
Baxter International Inc. is a global healthcare company specializing in a diverse range of medical products and therapies. Its core offerings include sterile intravenous solutions, infusion systems, and essential pharmaceuticals, serving critical needs in hospitals and various healthcare settings. Baxter's value proposition centers on providing life-sustaining and life-improving products, encompassing surgical tools, patient monitoring technologies, and respiratory care devices. The company's comprehensive product portfolio is distributed through a multi-channel approach, leveraging direct sales, distributors, and strategic partnerships. Operating internationally, Baxter's products are utilized across a broad spectrum of healthcare environments, making it a significant player in the global medical products market.
BAX is currently trading at $17.85, giving Baxter International Inc. a market cap of 8.85B. Today's range spans $18.00–$18.01, with shares opening at $18.01 and moving up $0.21 (1.2%) from the prior close. DailyIQ's technical score sits at 59/100 (HOLD) with a news sentiment reading of 55/100.
Over the past year BAX has traded between $15.73 and $32.68 - the current price is +13.5% off the 52-week low and -45.4% from the high. 26 analysts cover the stock with a Hold consensus and a mean 12-month target of $21.77 (range $15.00–$40.00), implying upside of +22.0%.
The data doesn't make a strong case for BAX right now: 59/100 technical score (HOLD), neutral sentiment (55/100), price $17.85 (near 52-week lows). For a small-cap with 8.85B in Healthcare market cap, this kind of setup often leads to rangebound or drifting price action - the kind of environment where holding the stock has opportunity cost and the exit is easier said than done in thin markets. Annual range: $15.73–$32.68.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $0.32 | - | - |
| Q4'25 | $0.33 | $0.44 | +34.0% |
| Q3'25 | $0.60 | $0.69 | +15.4% |
| Q2'25 | $0.61 | $0.54 | -11.5% |
| Q1'25 | $0.48 | $0.55 | +13.8% |
| Q4'24 | $0.53 | $0.58 | +9.6% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $2.6B | - | - |
| Q4'25 | $2.6B | $3.0B | +14.2% |
| Q3'25 | - | $2.8B | - |
| Q2'25 | - | $2.8B | - |
| Q1'25 | - | $2.6B | - |
| Q4'24 | - | $2.8B | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).